Revamped Pharmaceuticals Technology Upgradation Assistance Scheme:
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers has announced the Revamped Pharmaceuticals Technology Upgradation Assistance (RPTUAS) Scheme.
- Revamped Pharmaceuticals Technology Upgradation Assistance Scheme is to offer “subsidies based on quality” reimbursement, aiding pharmaceutical companies in achieving revised Schedule M and WHO-GMP certifications.
- The revised guideline aims to support the pharmaceutical industry’s up-gradation to the Revised Schedule-M & WHO-GMP standards, enhancing the quality and safety of pharmaceutical products manufactured in our country.
- Features of the Revised Scheme:
- Reflecting a more inclusive approach, eligibility for the PTUAS has been expanded beyond Micro, Small and Medium Enterprises to include any pharmaceutical manufacturing unit with a turnover of less than 500 crores that requires technology and quality upgradation. Preference remains for MSMEs, supporting smaller players in achieving high-quality manufacturing standards.
- The scheme introduces more flexible financing options, emphasizing subsidies on reimbursement basis, over traditional credit-linked approach.
- In alignment with revised Schedule-M and WHO- Good Manufacturing Practice (GMP) standards, the scheme now supports a broader range of technological upgrades. Eligible activities include improvements such as HVAC systems, water and steam utilities, testing laboratories etc.
- The revised scheme allows integration with state government schemes, enabling units to benefit from additional top-up assistance. This collaborative approach aims to maximize support for the pharmaceutical industry in their technology upgradation efforts.
- The new benefit limit is based on turnover of the company. Units with less than Rs 5 crore turnover will get an incentive of 20 percent of investment under eligible activities.
- The units with turnover ranging from Rs 50 crore to less than Rs 250 crore will get an incentive of 15 percent of investment, while for those with turnover ranging from Rs 250 crore to less than Rs 500 crore, it will be 10 percent of investment under eligible expenses.
